Abstract
Perioperative administration of a COX-2 inhibitor has demonstrated decreased in-hospital narcotic requirements and improved knee range of motion after total knee arthroplasty (TKA). The purpose of this study was to determine what benefits resulted from an additional 6 weeks of COX-2 inhibitor treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
